Nilogen Oncosystems Announces Partnership with Scailyte AG to Provide Clinically Relevant Translational Platform Supporting Development of Immuno-Oncology Therapeutics in Oncology Clinical Trials ...
TAMPA, Fla. and BASEL, Switzerland, July 12, 2022 /PRNewswire/ -- Nilogen Oncosystems, a leading Oncology drug development Company; and Scailyte, ...
Source: businessinsider.com